FDA Only Reports One Shrimp Refusal for Antibiotics in April

In April, the U.S. Food and Drug Administration (FDA) reported that just 1 out of the 88 (1.1%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics.

The table below summarizes shrimp entry line refusals for reasons related to veterinary drug residues from 2002 through April 2019.


The sole shrimp entry line refused in April for veterinary drug residues was from the United Arab Emirates:

  • Freshly Frozen Foods (United Arab Emirates), a company that is has been listed on Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) since June 27, 2018 for nitrofurans in its shrimp shipments, had one entry line refused for shrimp contaminated with nitrofurans by the Division of Southwest Imports on April 10, 2019.

After refusing 26 Indian shrimp entry lines in January for the presence of banned antibiotics, the FDA has reported refusing only six shrimp entry lines for the same reasons over the last three months.

Share This Article

Join the Mailing List

Get news from Southern Shrimp Alliance straight to your inbox!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Related Posts